Status: current, Primitive. Date: 31-Jul 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3304446011 | Idarucizumab (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3304447019 | Idarucizumab | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Idarucizumab | Is a | Monoclonal antibody | true | Inferred relationship | Some | ||
| Idarucizumab | Is a | Antidote | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Idarucizumab only product | Has active ingredient | True | Idarucizumab | Inferred relationship | Some | 1 |
| Idarucizumab only product in parenteral dose form | Has active ingredient | True | Idarucizumab | Inferred relationship | Some | 1 |
| Idarucizumab 50 mg/mL solution for infusion and/or injection | Has precise active ingredient | True | Idarucizumab | Inferred relationship | Some | 1 |
| Idarucizumab 50 mg/mL solution for infusion and/or injection | Has BoSS | True | Idarucizumab | Inferred relationship | Some | 1 |
| Idarucizumab-containing product | Has active ingredient | True | Idarucizumab | Inferred relationship | Some | 1 |
| Idarucizumab-containing product in parenteral dose form | Has active ingredient | True | Idarucizumab | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
Australian dialect reference set
FHIR